Diabetes Drugs and Diagnostics Market Size, Report 2026-34

Diabetes Drugs and Diagnostics Market Report by Segment (Oral Antidiabetics, Insulin, Diabetes Diagnostics), and Region 2026-2034

Report Format: PDF+Excel | Report ID: SR112026A2034

Buy Now

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Diabetes Disease Overview
4.1 What is Diabetes?
4.2 Diabetes Diagnosis and Treatment
4.2.1 Diagnosis
4.2.2 Treatment
4.3 Diabetes Complications
5 Key Factors Driving the Global Diabetes Market
6 Global Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 Global Diabetes Drugs and Diagnostics Market
7.1 Historical Market Trends
7.2 Market Breakup by Segment
7.3 Market Breakup by Region
7.4 Market Forecast
7.5 Top Selling Diabetes Drugs
7.5.1 Lantus (Sanofi)
7.5.2 Januvia (Merck And Co)
7.5.3 Humalog (Eli Lily and Co)
7.5.4 Novorapid/Novolog (Novo Nordisk)
7.5.5 Levemir (Novo Nordisk)
7.5.6 Victoza (Novo Nordisk)
7.5.7 Janumet (Merck And Co.)
7.5.8 Humulin (Eli Lily and Co.)
7.5.9 Toujeo (Sanofi)
7.6 SWOT Analysis
7.6.1 Overview
7.6.2 Strengths
7.6.3 Weaknesses
7.6.4 Opportunities
7.6.5 Threats
7.7 Value Chain Analysis
7.8 Porter’s Five Forces Analysis
7.8.1 Overview
7.8.2 Bargaining Power of Buyers
7.8.3 Bargaining Power of Suppliers
7.8.4 Degree of Competition
7.8.5 Threat of New Entrants
7.8.6 Threat of Substitutes
8 Market by Segment
8.1 Global Oral Antidiabetics Market
8.1.1 Historical Market Trends
8.1.2 Market Breakup by Class
8.1.2.1 Biguanides
8.1.2.2 Alpha-Glucosidase Inhibitors
8.1.2.3 Sodium-Glucose Cotransport -2 Inhibitors (SGLT-2 Inhibitors)
8.1.2.4 Dipeptidyl Peptidase-4 Inhibitors (DPP-4 Inhibitors)
8.1.2.5 Sulfonylureas
8.1.2.6 Dopamine -D2 Receptor Agonist
8.1.2.7 Others
8.1.3 Key Players
8.1.4 Market Outlook
8.2 Global Insulin Market
8.2.1 Historical Market Trends
8.2.2 Market Breakup by Class
8.2.2.1 Long Acting Insulin
8.2.2.2 Fast Acting Insulin
8.2.2.3 Short Acting
8.2.2.4 Others
8.2.3 Key Players
8.2.4 Market Outlook
8.3 Global Diabetes Diagnostics Market
8.3.1 Historical Market Trends
8.3.2 Market Breakup by Product Type
8.3.2.1 Blood Glucose Meters
8.3.2.2 Blood Glucose Strips
8.3.2.3 Lancets
8.3.3 Market Breakup by End-User
8.3.3.1 Hospitals and Clinics
8.3.3.2 Home Healthcare
8.3.3.3 Ambulatory Care Centers
8.3.3.4 Others
8.3.4 Key Players
8.3.5 Market Outlook
9 Market by Region
9.1 North America
9.1.1 Historical Market Trends
9.1.2 Market Outlook
9.2 Europe
9.2.1 Historical Market Trends
9.2.2 Market Outlook
9.3 Asia Pacific
9.3.1 Historical Market Trends
9.3.2 Market Outlook
9.4 Middle East and Africa
9.4.1 Historical Market Trends
9.4.2 Market Outlook
9.5 Latin America
9.5.1 Historical Market Trends
9.5.2 Market Outlook
10 Competitive Landscape
10.1 Market Structure
10.2 Key Player Profiles
10.2.1 Abbott Laboratories
10.2.2 AstraZeneca plc
10.2.3 B. Braun Medical Ltd
10.2.4 Dexcom, Inc
10.2.5 Eli Lilly and Company
10.2.6 Insulet Corporation
  10.2.7 Janssen Pharmaceuticals Inc. (Johnson & Johnson)
  10.2.8 LifeScan IP Holdings, LLC
  10.2.9 Medtronic plc
  10.2.10 Merck & Co. Inc.
  10.2.11 Novo Nordisk A/S
  10.2.12 Roche Diabetes Care, Inc (F. Hoffmann-La Roche AG)
  10.2.13 Sanofi-Aventis U.S. LLC (Sanofi S.A.)

List of Figures

Figure 1: The Impact of Diabetes on the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Overweight & Obese Population (in Million), 2015, 2020 & 2026
Figure 4: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 5: Global: Breakup of Diabetes Patients by Region (in %), 2020 & 2026
Figure 6: Global: Total Number of Diabetes Patients (in Millions), 2020-2025
Figure 7: Global: Total Number of Diabetes Patients Forecast (in Millions), 2026-2034
Figure 8: Global (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2020-2025
Figure 9: Global (Type1 & Type2): Total Number of Diabetes Patients Forecast (in Millions), 2026-2034
Figure 10: Global: Total Number of Diabetes Patients by Region (in Millions), 2020-2025
Figure 11: Global: Total Number of Diabetes Patients Forecast by Region (in Millions), 2026-2034
Figure 12: Global (Male & Female): Total Number of Diabetes Patients (in Millions), 2020-2025
Figure 13: Global (Male & Female): Total Number of Diabetes Patients Forecast (in Millions), 2026-2034
Figure 14: Global: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in Million), 2020-2025
Figure 15: Global: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, in Million), 2026-2034
Figure 16: Global: Diabetes Drugs and Diagnostics Market: Major Drivers and Challenges
Figure 17: Global: Diabetes Drugs and Diagnostics Market: Value Trends (in Billion USD), 2020-2025
Figure 18: Global: Diabetes Drugs and Diagnostics Market: Breakup by Segment (in %), 2025
Figure 19: Global: Diabetes Drugs and Diagnostics Market: Breakup by Region (in %), 2025
Figure 20: Global: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Billion USD), 2026-2034
Figure 21: Global: Oral-Antidiabetics Market: Value Trends (in Million USD), 2020-2025
Figure 22: Global: Oral-Antidiabetics Market: Breakup by Class (in %), 2025
Figure 23: Global: Oral-Antidiabetics Market Forecast: Value Trends (in Million USD), 2026-2034
Figure 24: Global: Insulin Market: Value Trends (in Million USD), 2020-2025
Figure 25: Global: Insulin Market: Breakup by Class (in %), 2025
Figure 26: Global: Insulin Market Forecast: Value Trends (in Million USD), 2026-2034
Figure 27: Global: Diabetes Diagnostics Market: Value Trends (in Million USD), 2020-2025
Figure 28: Global: Diabetes Diagnostics Market: Breakup by Product Type (in %), 2025
Figure 29: Global: Diabetes Diagnostics Market: Breakup by End-User (in %), 2025
Figure 30: Global: Diabetes Diagnostics Market Forecast: Value Trends (in Million USD), 2026-2034
Figure 31: North America: Diabetes Drugs and Diagnostics Market: Value Trends (in Million USD), 2020-2025
Figure 32: North America: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million USD), 2026-2034
Figure 33: Europe: Diabetes Drugs and Diagnostics Market: Value Trends (in Million USD), 2020-2025
Figure 34: Europe: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million USD), 2026-2034
Figure 35: Asia Pacific: Diabetes Drugs and Diagnostics Market: Value Trends (in Million USD), 2020-2025
Figure 36: Asia Pacific: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million USD), 2026-2034
Figure 37: Middle East and Africa: Diabetes Drugs and Diagnostics Market: Value Trends (in Million USD), 2020-2025
Figure 38: Middle East and Africa: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million USD), 2026-2034
Figure 39: Latin America: Diabetes Drugs and Diagnostics Market: Value Trends (in Million USD), 2020-2025
Figure 40: Latin America: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million USD), 2026-2034
Figure 41: Global: Diabetes Drugs and Diagnostics Industry: SWOT Analysis
Figure 42: Global: Diabetes Drugs and Diagnostics Industry: Value Chain Analysis
Figure 43: Global: Diabetes Drugs and Diagnostics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Diabetes Drugs and Diagnostics Market: Industry Overview
Table 2: Diagnosis of Diabetes
Table 3: Global: Overweight & Obesity Statistics, 2005, 2010 & 2019
Table 4: Global: Diabetes Population Breakup by Region (in 000’s), 2020 & 2026
Table 5: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
Table 6: Global: Total Prevalence & Number of Diabetes Patients (in Million), 2020, 2026 & 2034
Table 7: Global (Type1 & Type2): Total Prevalence & Number of Diabetes Patients (in Million), 2020, 2026 & 2034
Table 8: Global (Male & Female): Total Prevalence & Number of Diabetes Patients (in Million), 2020, 2026 & 2034
Table 9: Global: Total Prevalence & Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79- in Million), 2020, 2026 & 2034
Table 10: Global: Diabetes Drugs and Diagnostics Market: Key Industry Highlights 2025 and 2034
Table 11: Global: Oral-Antidiabetics Market: Key Industry Highlights 2025 and 2034
Table 12: Global: Insulin Market: Key Industry Highlights 2025 and 2034
Table 13: Global: Diabetes Diagnostics Market: Key Industry Highlights 2025 and 2034

Purchase Options Discount
Offer

Request Customization

Speak to an Analyst

Request Brochure

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: [email protected]

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.